Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 2-phenylacetamide | 103-81-1 | MFCD00059193 | 99.9% | 135.17 g/mol | C8H9NO | 10 G
SDP

Catalog No. 5000301436
Encompass_Preferred

2-Phenylacetamide (CAS 103-81-1) is a small-molecule research compound (molecular formula C8H9NO, molecular weight 135.17 g/mol) reported to inhibit the p38 MAPK signaling pathway and to exhibit anti-inflammatory, antioxidant, anti-hypertensive, and anti-fibrosis effects. It is supplied as a solid at research-grade purity for biochemical and pharmacological studies.

  • High purity suitable for research applications.
  • Reported p38 MAPK pathway inhibitory activity.
  • Available in multiple pack sizes, including 10 g.
  • Supplied as a solid with molecular formula C8H9NO.
  • Useful for biochemical, pharmacological, and pathway-modulation studies.

Catalog No. 50-003-01436 Supplier Medchemexpress LLC Supplier No. HYW01819710G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

2-Phenylacetamide (CAS 103-81-1) is a small-molecule research compound (molecular formula C8H9NO, molecular weight 135.17 g/mol) reported to inhibit the p38 MAPK signaling pathway and to exhibit anti-inflammatory, antioxidant, anti-hypertensive, and anti-fibrosis effects. It is supplied as a solid at research-grade purity for biochemical and pharmacological studies.

  • High purity suitable for research applications.
  • Reported p38 MAPK pathway inhibitory activity.
  • Available in multiple pack sizes, including 10 g.
  • Supplied as a solid with molecular formula C8H9NO.
  • Useful for biochemical, pharmacological, and pathway-modulation studies.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.